Trial Profile
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PHP-303 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2020
Price :
$35
*
At a glance
- Drugs PHP 303 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors pH Pharma
- 12 Dec 2018 Status changed from recruiting to completed.
- 22 Aug 2018 New trial record